Numerous microbial pathogens modulate or interfere with cell death pathways in cultured cells. However, the precise role of host cell death during in vivo infection remains poorly understood. Macrophages infected by pathogenic species of Yersinia typically undergo an apoptotic cell death. This is due to the activity of a Type III secreted effector protein, designated YopJ in Y. pseudotuberculosis and Y. pestis, and YopP in the closely related Y. enterocolitica. It has recently been reported that Y. enterocolitica YopP shows intrinsically greater capacity for being secreted than Y. pestis YopJ, and that this correlates with enhanced cytotoxicity observed for high virulence serotypes of Y. enterocolitica. The enzymatic activity and secretory capacity of YopP from different Y. enterocolitica serotypes have been shown to be variable. However, the underlying basis for differential secretion of YopJ/YopP, and whether reduced secretion of YopJ by Y. pestis plays a role in pathogenesis during in vivo infection, is not currently known. It has also been reported that similar to macrophages, Y. enterocolitica infection of dendritic cells leads to YopP-dependent cell death. We demonstrate here that in contrast to Y. enterocolitica, Y. pseudotuberculosis infection of bone marrow–derived dendritic cells does not lead to increased cell death. However, death of Y. pseudotuberculosis–infected dendritic cells is enhanced by ectopic expression of YopP in place of YopJ. We further show that polymorphisms at the N-terminus of the YopP/YopJ proteins are responsible for their differential secretion, translocation, and consequent cytotoxicity. Mutation of two amino acids in YopJ markedly enhanced both translocation and cytotoxicity. Surprisingly, expression of YopP or a hypersecreted mutant of YopJ in Y. pseudotuberculosis resulted in its attenuation in oral mouse infection. Complete absence of YopJ also resulted in attenuation of virulence, in accordance with previous observations. These findings suggest that control of cytotoxicity is an important virulence property for Y. pseudotuberculosis, and that intermediate levels of YopJ-mediated cytotoxicity are necessary for maximal systemic virulence of this bacterial pathogen.
The ability of bacterial pathogens to modulate death of infected host cells is an important virulence determinant. For pathogenic members of the genus Yersinia, the type III secreted effector protein YopJ/YopP is required for Yersinia-induced macrophage death. The YopJ protein is expressed by Y. pseudotuberculosis, while the ninety-four percent identical YopP protein is expressed by Y. enterocolitica. Y. enterocolitica infection also triggers YopP-dependent killing of dendritic cells, which are critical antigen presenting cells of the immune system. We demonstrate that in contrast to macrophages, dendritic cells are resistant to Y. pseudotuberculosis-mediated cytotoxicity. However, Y. pseudotuberculosis expressing YopP in place of YopJ was highly cytotoxic toward dendritic cells. This difference in cytotoxicity was attributable to a difference in the delivery of YopJ and YopP into mammalian cells. Furthermore, mutation of two amino acids at the N-terminus of YopJ enhanced its delivery and cytotoxicity. Remarkably, we found that enhancing the cytotoxicity of Y. pseudotuberculosis by expression of YopP led to its attenuation in a mouse model of Yersinia infection. This indicates that optimal virulence for a given pathogen requires careful regulation of virulence properties and highlights the potential evolutionary tradeoffs between cellular cytotoxicity and in vivo virulence.
Citation: Brodsky IE, Medzhitov R (2008) Reduced Secretion of YopJ by Yersinia Limits In Vivo Cell Death but Enhances Bacterial Virulence. PLoS Pathog 4(5): e1000067. doi:10.1371/journal.ppat.1000067
Editor: Ralph R. Isberg, Tufts University School of Medicine, United States of America
Received: February 15, 2008; Accepted: April 11, 2008; Published: May 16, 2008
Copyright: © 2008 Brodsky, Medzhitov. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the New England RCE, AI057159. IB is supported by a postdoctoral NRSA grant 1 F32 AI065081. RM is an investigator of the Howard Hughes Medical Institute.
Competing interests: The authors have declared that no competing interests exist.
It is generally thought that the ability of bacterial pathogens to cause host cell death in vitro is important for virulence in vivo . However the role of host cell killing in bacterial virulence during in vivo infections remains poorly understood. Whether a particular optimal level of cell death might exist during bacterial infection, and how such a level might be achieved is a question that has not yet been addressed. Standard genetic approaches to investigate the basis of microbial pathogenesis typically screen or select for loss of function mutants in which a particular virulence property is completely abrogated. However, modulating the level of activity of individual virulence factors by bacterial pathogens has been shown to be important for maximizing overall virulence. This may be because of two opposing selective pressures that act on any given virulence property: positive selection for enhanced bacterial replication is countered by a selection for reduced host detection. Thus, because host organisms possess mechanisms to sense infection and are likely to respond to disruption of signaling pathways, bacterial pathogens must evolve additional mechanisms for modulating an initial baseline activity of particular virulence factor. For example, during the process of cell invasion, the activity of the Salmonella GEF protein SopE is counteracted by the phosphatase SptP , and this activity of SptP is important for limiting TNF-α production by Salmonella infected cells . Additionally, replacement of the Listeria monocytogenes pore-forming toxin LLO with the related but much more active toxin PFO leads to attenuated bacterial replication in vitro and in vivo . We wished to examine whether bacterial proteins that trigger cell death might also possess an optimal level of activity for a given bacterial pathogen. We therefore devised a system in which the cytotoxicity of the facultative extracellular pathogen Yersinia pseudotuberculosis could be altered in a tunable fashion. This approach enabled us to uncover a requirement for limiting the extent of cell death during the course of animal infection that has not previously been appreciated in studies of Yersinia virulence.
The Gram negative genus Yersinia contains three pathogenic species whose close evolutionary relationship provides an ideal system with which to investigate the evolution of bacterial virulence . Y. pestis (the etiologic agent of plague) and Y. pseudotuberculosis are the most closely related, with Y. pestis believed to have recently evolved from Y. pseudotuberculosis . Y. enterocolitica comprises a more distantly related, heterogeneous group of biotypes that are both highly pathogenic and non-pathogenic in animal infection models. A common feature of Yersinia infection is a tropism for lymphoid tissues. Interestingly, despite the shared enteric lifestyle of Y. pseudotuberculosis and Y. enterocolitica, highly virulent serotypes of the latter appear to trigger more acute pathology in infected tissues, and have a 10-50-fold lower LD50 in experimental mouse infections ,. This difference in pathology and virulence characteristics may reflect diverse selection pressures faced by these two species over the course of their evolution away from a common ancestor.
All three pathogenic Yersinia species harbor a virulence plasmid of approximately 70 kB that encodes a Type III Secretion System (TTSS) as well as secreted effector proteins designated Yersinia outer proteins or Yops ,. The virulence plasmid interferes with key immune functions during infection ,,,. However, the tropism of Yersinia species for lymphoid tissue appears to be dependent upon bacterial chromosomal factors, as bacteria lacking the virulence plasmid can still colonize mesenteric lymph nodes following oral infection .
Among the best studied aspects of Yersinia infection is its cytotoxicity toward mammalian macrophages. This cytotoxicity is caused by a type III secreted effector protein, designated YopJ in Y. pestis and pseudotuberculosis and YopP in Y. enterocolitica ,. YopJ and YopP interfere with NF-kB and MAPK signaling pathways in infected cells, leading to a block in cytokine secretion and macrophage death ,. Studies have suggested that the mechanism of YopJ activity lies in its ability to deubiquitinate signaling proteins, including TRAF6 and IKKβ, that are required for NF-κB and MAPK responses to bacterial infection 19,20. More recent studies propose that YopJ/P acylates substrates such as MKK6 and MEK2 which prevents their subsequent phosphorylation and activation ,. Regardless of the precise mechanism, it is clear that one of the major consequences of Yersinia infection is the YopJ/P-dependent death of infected macrophages, and that YopJ contributes to systemic virulence following mouse oral infection .
Despite the close evolutionary relationship between the pathogenic Yersiniae, heterogeneity exists among Yersinia enterocolitica isolates with respect to the presence or absence of a high-affinity iron-transport system encoded by the high pathogenicity island (HPI) ,, and presence or absence of YopT among Y. pseudotuberculosis isolates . It has also been observed that YopP of different Y. enterocolitica serotypes can differ in enzymatic activity due to the presence of an arginine/serine polymorphism at amino acid 143 . The presence of R143 correlates with high virulence among Y. enterocolitica isolates . Although YopJ of Y. pestis and Y. pseudotuberculosis contains the R143 polymorphism associated with higher activity, it was recently shown that YopP from the high-virulence Y. enterocolitica O∶8 serotype is more cytotoxic to macrophages than YopJ of Y. pestis, and expression of YopP in Y. pestis increases its in vitro cytotoxicity . This difference in cytotoxicity was shown to be due to an increase in the secretion of YopP relative to YopJ of Y. pestis. However, the basis for reduced secretion of YopJ, and whether control of Yop secretion plays a role in Yersinia virulence in vivo remains unknown.
Studies on the interaction of Y. enterocolitica and DCs have suggested that like macrophages, DCs are highly susceptible to killing by Yersinia infection, and that this killing is dependent upon the activity of YopP . Other studies have indicated that killing of DCs by Y. enterocolitica interferes with the priming of adaptive T cell responses in infected mice . More recent work has further suggested that blocking of MAPK pathways by YopP in DCs infected by Y. enterocolitica prevents DC pinocytosis and antigen uptake .
Our initial examination of Y. pseudotuberculosis infection of DCs did not show high levels of cell death, although in accordance with previous studies, macrophages showed significant levels of cell death in response to the same infectious dose of Y. pseudotuberculosis. Our studies therefore reveal that DCs are markedly more resistant than macrophages to induction of cell death by Y. pseudotuberculosis, in contrast to previous reports indicating that both DC and macrophage cytotoxity is limited during Y. pestis infections ,. We suspected that Y. pseudotuberculosis may thus have evolved a species-specific means of reducing its cytotoxicity toward DCs. We demonstrate that two amino acid polymorphisms in the N-terminus of YopJ and YopP are responsible for controlling their levels of secretion and translocation, which correlates directly with the extent of cytotoxicity of Y. pseudotuberculosis relative to Y. enterocolitica and their differential ability to inhibit MAPK activation in infected dendritic cells. The biological importance of this reduced DC cytotoxicity was revealed upon infection of mice with Y. pseudotuberculosis strains that differed in their cytotoxicity toward DCs: surprisingly, we found that enhancing cytotoxicity of Y. pseudotuberculosis resulted in its attenuation following oral infection. This level of attenuation was similar to that seen with a yopJ deficient strain of Y. pseudotuberculosis . These data suggest that maximal virulence of Y. pseudotuberculosis requires an intermediate level of YopJ-mediated cytotoxicity.
Dendritic cells are more resistant than macrophages to apoptosis induced by YopJ but not YopP
We initiated our studies by examining the extent of cell death in macrophages and dendritic cells infected with Y. pseudotuberculosis and Y. enterocolitica. Macrophage death following infection with Yersinia occurs through caspase-3 by a pathway involving Bid cleavage . We therefore examined cleavage of the Caspase-3 substrate poly-ADP ribose polymerase (PARP) as a means of comparing the extent of cell death in macrophages and dendritic cells (DCs). PARP was cleaved in macrophages infected either with Y. enterocolitica or Y. pseudotuberculosis at low and high MOI, as expected (Figure 1A). However, DCs infected with Y. pseudotuberculosis showed no cleavage of PARP at low MOI, and only very low levels of PARP cleavage at high MOI. This was in contrast to DCs infected with Y. enterocolitica, which had high levels of PARP cleavage at both low and high MOI (Figure 1B). Death of Yersinia-infected macrophages is mediated by the YopJ/YopP proteins ,. We therefore used the low copy plasmid pACYC184 to complement a yopJ mutant of the Y. pseudotuberculosis strain IP2666 with either yopJ (called pYopJ) from Y. pseudotuberculosis or yopP (called pYopP) from Y. enterocolitica. Complementation with pYopJ or pYopP resulted in PARP cleavage in Y. pseudotuberculosis infected macrophages; however, only expression of YopP in Y. pseudotuberculosis enabled PARP cleavage in infected DCs (Figure 1A and 1B). We confirmed that caspase-3 was indeed differentially activated in DCs infected by these various strains of Yersinia using a cell-permeable fluorescent caspase-3 substrate. Consistent with the extent of PARP cleavage, a much greater percentage of cells activated caspase-3 following infection with either Y. enterocolitica or Y. pseudotuberculosis expressing YopP than cells infected with Y. pseudotuberculosis expressing YopJ (Figure 1C). Macrophages were not more permissive for Yop translocation than DCs, as equivalent levels of a YopE-β lactamase reporter fusion protein were translocated into both macrophages and DCs (Table S2). It is also unlikely that differential attachment of Y. pseudotuberculosis to DCs accounts for the observed difference, as expression of YopP alone in Y. pseudotuberculosis was sufficient to cause markedly increased caspase-3 activation and PARP cleavage in DCs.
(A) PARP cleavage was measured by immunoblotting of macrophage and (B) dendritic cell lysates after infection with indicated Y. pseudotuberculosis (Yp) and Y. enterocolitica (Ye) strains at indicated multiplicity of infection (MOI). P- indicates bacteria lacking the virulence plasmid. Immunoblots are representative of 3 independently infected preparations of cells. (C) NucView™ 488 Caspase-3 fluorescent substrate labeling of dendritic cells infected at an MOI of 5 with indicated bacterial strains.
MAPK activation in dendritic cells is more potently inhibited by YopP than YopJ
The observation of increased PARP cleavage and caspase-3 activation in DCs infected with Y. pseudotuberculosis expressing YopP but not YopJ suggested an intrinsic difference between YopJ and YopP. Recent studies showed that although Y. pestis and Y. enterocolitica infection show equivalent inhibition of macrophage p38 MAPK activation, Y. pestis YopJ and Y. enterocolitica YopP are differentially translocated into infected macrophages . Macrophages infected by Yersinia are thought to undergo cell death due to inhibition of NF-κB and MAPKs by YopJ/P in the context of stimulation by bacterial LPS ,. This is due to the requirement for NF-κB and MAPK signaling in the synthesis of anti-apoptotic gene products following treatment with pro-inflammatory stimuli .We therefore examined MAPK activation in dendritic cells following Yersinia infection.
As anticipated, DCs infected with virulence plasmid-deficient bacteria of either species rapidly phosphorylated p38 and SAPK/JNK; in contrast, wild-type Y. enterocolitica completely blocked p38 and SAPK/JNK phosphorylation but Y. pseudotuberculosis did not (Figure 2A and B). This suggested that in contrast to prior observations in macrophages, dendritic cells are differentially sensitive to MAPK inhibition by YopJ or YopP. Indeed, the increased inhibition of MAPK activation in DCs infected with Y. enterocolitica was specifically due to YopP, as expression of YopP alone in Y. pseudotuberculosis was sufficient to inhibit p38 and SAPK/JNK phosphorylation to virtually the same extent as Y. enterocolitica (Figure 2C). Notably, kinetics of MAPK activation in cells infected with virulence plasmid- deficient bacteria differed markedly between Y. enterocolitica and Y. pseudotuberculosis: activation of both p38 and SAPK/JNK was much more rapid in YeP- infected cells than YpP- infected cells. This may be due to subtle differences in the LPS of Y. enterocolitica and Y. pseudotuberculosis, as heat killed bacteria showed similar differences in kinetics of MAPK activation (data not shown). We did not observe differential inhibition of NF-κB activation in DCs infected with Y. enterocolitica and Y. pseudotuberculosis (data not shown). This suggested that increased MAPK inhibition was primarily responsible for the increased death of DCs infected by Y. enterocolitica. Indeed, specific inhibition of p38 in the context of wild-type Y. pseudotuberculosis infection was sufficient to increase dendritic cell death to nearly the same extent as cells infected by Y. enterocolitica (Figure 2D). That this effect was not due to nonspecific increase in death was demonstrated by LPS-treated DCs or DCs infected with Y. pseudotuberculosis lacking the virulence plasmid, which did not show dramatically increased death upon p38 MAPK inhibition. Together with the PARP cleavage, these data indicated that an intrinsic difference between the YopJ and YopP proteins was most likely responsible for the differences in phenotypes observed between Y. enterocolitica and Y. pseudotuberculosis.
(A) Cell lysates from dendritic cells infected for indicated number of minutes with wild type Y. pseudotuberculosis or enterocolitica (Yp or Ye, respectively) or their virulence plasmid-deficient counterparts (YpP- or YeP-) were probed for phospho-p38 and total p38. (B) Identical cell lysates as in (A) were probed for phospho-SAPK/JNK and total SAPK/JNK. (C) Cell lysates from dendritic cells infected with Yp ΔyopJ expressing either YopP or YopJ as indicated were probed for phospho- and total-MAPK proteins as in (A) and (B). All immunoblots are representative of three independently performed experiments. (D) Flow cytometry analysis of annexinV-positive DCs treated with vehicle (DMSO) or the p38 inhibitor SB202190 immediately prior to being left untreated, treated with LPS, or infected with Yp, YpP-, Ye, or YeP-. Data are represented as bar graphs of the mean of triplicate samples, and are representative of three independently performed experiments.
Enhanced dendritic cell death in Y. enterocolitica-infected cells is due to N-terminal polymorphisms that enhance secretion and translocation of YopP relative to YopJ
Recent work has indicated that Y. pestis YopJ and Y. enterocolitica YopP are differentially translocated into infected macrophages when expressed from a strong promoter on a high-copy plasmid . However, the basis for this differential translocation is unknown. We therefore examined the in vitro secretion of Yops from a yopJ mutant of Y. pseudotuberculosis expressing YopJ or YopP on a low copy plasmid, as well as from wild-type Y. pseudotuberculosis and Y. enterocolitica. Similarly to published observations ,, YopJ of Y. pseudotuberculosis was poorly detected in bacterial culture supernatants, in contrast to YopP which was easily observed by SDS-PAGE of TCA-precipitated Yersinia culture supernatants (Figure 3A). YopP ectopically expressed in Y. pseudotuberculosis also was secreted at higher levels than YopJ (Figure 3A). The yopP coding sequence alone was sufficient for this enhanced secretion, since replacement of the yopJ protein coding sequence with that of yopP, generating a plasmid designated pYopJP, resulted in markedly greater levels of protein secretion than the pYopJ or the converse pYopPJ plasmid (Figure 3A). A schematic diagram of the construction of pYopJP and pYopPJ is provided in supporting information (Figure S1A).
(A) TCA-precipitated supernatants from indicated bacterial strains analyzed by SDS-PAGE and Coomassie blue staining. (B) Cell lysates from HeLa cells infected with yopJ mutant Y. pseudotuberculosis expressing indicated GSK fusion proteins analyzed by Western blotting for levels of translocation of GSK fusion protein (anti-phospho-Ser9-GSK) and for levels of total GSK fusion protein (anti-GSK3β aa1-13). White arrow indicates phospho-GSK fusion protein, black arrow indicates total GSK-tagged fusion protein. Grey arrows indicate endogenous phospho-GSK and GSK. (C) Percentage of bone marrow derived macrophages that stain positively with annexinV/propidium iodide (PI) 8 hrs post-infection at MOI of 20 with indicated bacterial strains. Dotted line indicates background staining of uninfected cells. (D) Percentage of bone marrow derived dendritic cells that stain positively with PI 16–18 hrs post-infection at MOI of 20 with indicated bacterial strains. Graphs are representative of 3 independently infected preparations of cells, performed in triplicate. p values obtained by Student's unpaired two-tailed t-test.
Type III secretion in Yersinia is thought to depend upon both mRNA and primary amino acid sequences within the first 10–15 codons/amino acids of the secreted effector protein ,,,. We examined this region of YopP and YopJ for insight into the basis of their differential secretion. The coding sequences of yopP and yopJ have four nucleotide polymorphisms within this region (Figure S1B). Two of these polymorphisms are synonomous changes, while two are non-synonomous, resulting in an IS to SP change at amino acids 10 and 11. We therefore generated mutations in the yopJ coding sequence of plasmids pYopJ and pYopPJ, creating substitutions in all 4 polymorphic nucleotides. These plasmids were designated pYopJn or pYopPJn, and demonstrate that whereas wild-type YopJ is poorly secreted, mutation of 4 nucleotides at the 5′ end of yopJ is sufficient to markedly enhance secretion of YopJ (Figure 3A, compare YopPJ to YopPJn). We separated the non-synonomous and synonomous mutations by making constructs pYopPJ2aa, with IS→SP amino acid changes in YopJ, and pYopPJ2nt, with two nucleotide changes in yopJ but no alteration of the YopJ protein sequence (Figure S1C). Mutation of IS→SP was in fact sufficient to enhance YopJ secretion, indicating that the YopJ/P amino acid sequence was primarily responsible for the level of secretion (Figure S1D). In order to measure the amount of protein actually translocated into infected cells, we constructed reporter plasmids encoding a GSK tag in the pYopJ, pYopP, pYopJn and pYopPJn plasmids. This tag is phosphorylated by host cell Ser/Thr kinases only upon translocation of the fusion protein into the cytosol, and is therefore a useful tool to measure the extent of protein translocation . Indeed, we observed that the translocation of YopP and YopPJn was significantly higher than that of YopJ and YopJn, as detected by levels of phospho-GSK fusion protein (Figure 3D, left panel). Furthermore, levels of translocated YopJn were notably higher than levels of translocated YopJ. The amount of total GSK fusion protein was similar for all of the constructs (Figure 3D, right panel), indicating that differences in steady-state level of total protein were not responsible for differences in translocation.
We next examined the extent of cell death caused by infection with Y. pseudotuberculosis strains harboring these plasmids. As expected and consistent with the known role of of YopJ/P in macrophage death, an increase in macrophage cell death occurred upon infection with any of the strains containing pYopJ, pYopP or chimeric and mutant, but not vector control, plasmids, demonstrating their functionality (Figure 3C). In contrast, death of DCs occurred only when they were infected by strains containing plasmids mediating high levels of YopJ/P protein secretion, specifically pYopP, pYopJP, and pYopPJn (Figure 3D). These plasmids also mediate high levels of Yop/P protein translocation, suggesting that increased levels of translocated YopJ/P are directly responsible for increased death of DCs. Interestingly, although YopJn-GSK was also translocated at higher levels than YopJ-GSK, this was not enough to markedly enhance the level of cell death in DCs infected with YopJn-expressing bacteria (Figure 3D). This suggests that a fairly high threshold of YopJ activity is necessary to induce death of DCs, and that this threshold is significantly higher than for macrophages. Together, these results indicate that Y. enterocolitica has much greater levels of cytotoxicty toward DCs than Y. pseudotuberculosis, that this cytotoxicity is dependent upon the degree of YopP secretion and translocation, and that the cytotoxicity of Y. pseudotuberculosis toward DCs can be significantly increased by inducing high levels of YopJ translocation.
Evolutionary selection for differential secretion of YopP and YopJ
Y. enterocolitica comprises a heterogeneous group of strains that differ with respect to their degree of virulence in animal infections. The primary basis for this difference is the presence or absence of a ‘High pathogenicity island’ (HPI) encoding an iron transport system . Interestingly, the presence of the HPI shows strong correlation with the presence of arginine at amino acid 143 of YopP . These two traits also correlate with apparently increased secretion of YopP, as the Y. enterocolitica serotypes which lack the HPI also appear to secrete less YopP . Based on our analysis of the N-terminal polymorphisms between YopP from Y. enterocolitica 8081 and Y. pseudotuberculosis YopJ, we examined YopP sequences from strains of Y. enterocolitica O∶8 (high virulence) and O∶9 (low virulence) serotypes, as well as YopJ sequences from Y. pestis. We found that all sequenced strains of Y. pestis and Y. pseudotuberculosis possess the same isoleucine-serine sequence at positions 10 and 11, which correlates with reduced secretion (Figure 4). In contrast, O∶8 serotype, high virulence, strains of Y. enterocolitica possess the serine-proline sequence which confers high secretion. Interestingly, the O∶9 serotype low virulence Y. enterocolitica strains also possessed a mutation at position 11, encoding a phenylalanine rather than serine found in YopP from high virulence strains (Figure 4). YopP from the low virulence O∶9 strains has been suggested to be secreted at lower levels than YopP expressed by O∶8 serotype strains . This raised the possibility that secretion of YopJ/YopP itself is a selectable trait that may play a differential role in virulence depending on the particular Yersinia species and serotype in which it is expressed. In order to examine this possibility in greater detail, we investigated the consequences of animal infection caused by Y. pseudotuberculosis expressing YopP or YopJ.
N-terminal 14 amino acids of YopP and YopJ from various Yersinia strains and serotypes. O∶8 serotypes of Y. enterocolitica possess an SP sequence at positions 10 and 11, whereas Y. pseudotuberculosis and Y. pestis possess the IS sequence. O∶9 serotypes of Y. enterocolitica also possess a polymorphism at amino acid 11, which likely accounts for the reduced secretion of YopP by O∶9 serotypes. Ye – Y. enterocolitica, Ype – Y. pestis, Yps – Y. pseudotuberculosis. Ype Med. – Y. pestis, biovar Medievalis.
YopP mediates greater cell death than YopJ in tissues during in vivo infection
Both Y. enterocolitica and Y. pseudotuberculosis cause cell death within infected tissues in vivo. Yet, a direct side-by-side comparison between the two species during in vivo infection is difficult due to unique gene products present or absent in one or the other species. We therefore directly examined the in vivo consequences of modulating Y. pseudotuberculosis cytotoxicity: we infected mice orally with either YopJ- or YopP-expressing Y. pseudotuberculosis and assayed the extent of cell death in infected tissues by terminal dUTP nick-end labeling (TUNEL) staining four days post-infection. Consistent with our in vitro observations, mice infected with the YopP-expressing strain of Y. pseudotuberculosis showed markedly increased levels of TUNEL-positive cells in mesenteric lymph nodes among both CD11b+ (primarily macrophage) and CD11c+ (primarily dendritic cell) populations (Figure 5A). B220+ (primarily B cell) populations also showed increased levels of TUNEL staining in mesenteric lymph nodes of mice infected with YopP-expressing bacteria relative to mice infected with YopJ-expressing bacteria (data not shown). This suggests that in vivo, multiple cell subsets are susceptible to Yersinia-induced cell death. Further microscopic examination also suggested than in mice infected with YopP-expressing bacteria, cell death was more widely distributed within the infected tissues, whereas in mice infected with YopJ-expressing bacteria, dead or dying cells were more tightly clustered within a smaller area (Figure 5B). In order to further corroborate and quantify these findings, we enumerated TUNEL+ cells in infected tissue sections. Significantly more TUNEL+ cells were present in the spleen and lymph node sections of mice infected with YopP-expressing bacteria than in the mice infected with YopJ-expressing bacteria, although no significant differences were observed in the Peyer's patches (Figure 5B). In vivo, higher numbers of CD11b+ cells were TUNEL+ in YopP-infected mice than YopJ-infected mice despite the observation that bone marrow derived macrophages were equally susceptible to death following infection with YopP- or YopJ-expressing bacteria (Figure 4B). However, we have observed that at low multiplicities of infection, YopP-expressing bacteria are more cytotoxic than YopJ-expressing bacteria to bone marrow derived macrophages as well (Figure S2). This may suggest that the actual multiplicity of infection within infected tissues is likely to be fairly low, even at later timepoints post-infection. An alternative possibility is that macrophages in vivo may behave slightly differently with respect to Yersinia-induced cell death than bone marrow derived macrophages in culture.
(A) TUNEL staining analyzed by flow cytometry of mesenteric lymph node cells isolated day 4 post-infection from mice given PBS as controls or infected with yopJ mutant Y. pseudotuberculosis expressing YopJ or YopP. CD11b and CD11c populations represent primarily macrophage and dendritic cell populations, respectively. Data are representative of six mice per group for infected mice and three mice for PBS controls. Percentage of double positive cells is indicated in each dot plot. Bar graphs represent mean percentage of double positive cells for six infected mice for each bacterial strain or three PBS control treated mice. (B) Spleen sections from mice infected with YopJ- or YopP- expressing bacteria as in (A), isolated on Day 4 post-infection and stained with TUNEL reagent and DAPI. Scale bar = 40 µM. (C) Enumeration of TUNEL+ nuclei from spleen, mesenteric lymph node, and Peyer's patch sections isolated four days post-infection with YopJ- (light grey bars) or YopP- (dark grey bars) expressing yopJ mutant Y. pseudotuberculosis. Data are averages of at least 10 random fields per mouse per tissue averaged from three mice per group. Similar results were obtained for two independent infections. p values were calculated using the unpaired Student's t-test.
Increased cytotoxicity attenuates in vivo virulence of Y. pseudotuberculosis
We investigated the impact of this increased cytotoxicity on the virulence of Y. pseudotuberculosis by examining bacterial growth in tissues of mice infected with the yopJ mutant strain reconstituted with either YopJ or YopP. Surprisingly, we found that the more cytotoxic (YopP-expressing) Y. pseudotuberculosis strain was attenuated following oral infection: mice infected with bacteria expressing YopP had significantly lower colony forming units (cfu) in the spleen at days 3 and 5 post-infection, and in mesenteric lymph nodes on day 5 post-infection (Figure 6A). Due to the acute nature of the infection, not enough mice infected with YopJ-expressing bacteria survived to be able to isolate tissues at day 7. The Y. pseudotuberculosis strain containing only the vector, and therefore completely lacking YopJ, was as deficient as the YopP-expressing strain for replicating in the spleen, consistent with the requirement of YopJ for this aspect of Yersinia virulence  (Figure 6A). Importantly, 97–100% of bacteria recovered from mouse tissues maintained the pYopJ or pYopP plasmids for at least seven days following oral infection, and the YopP-expressing bacteria maintained their increased in vitro cytotoxicity upon reisolation from infected organs (data not shown).
(A) Bacterial CFUs present in tissues of mice infected with Yp ΔyopJ containing either empty vector (white triangles) or expressing YopJ (grey squares) or YopP (grey circles) at days 3, 5, and 7 after oral infection. Mice infected with YopJ-expressing Yp ΔyopJ were moribund or dead from overwhelming infection at the end of day 6. (B) Serum cytokine levels of infected mice from (A) collected on days 3 (white bars), 5 (light grey bars), and 7 (dark grey bars). (C) Survival curve of mice infected with YopJ- (grey squares) or YopP- (grey circles) expressing Yp ΔyopJ. p values for bacterial cfu and serum cytokine levels were calculated using unpaired 2-tailed Student's t-Test. p value for mouse survival curves was calculated using log-rank test.
Levels of pro-inflammatory cytokines were markedly elevated in sera obtained from mice infected with YopJ-expressing bacteria compared with those infected either with YopP-expressing bacteria or the isogenic yopJ-deficient bacteria containing only vector (Figure 6B). Elevated levels of TNF-α and IL-6 were observed on day 3 post-infection, and rose dramatically along with IFN-γ and IL-12 on day 5, coincident with the increase in bacterial load in the spleen. Surprisingly, lower levels of cytokines were observed in mice infected with either YopP-expressing bacteria or bacteria lacking yopJ (vector), despite the ability of the mice to limit the systemic replication of these strains. Furthermore, survival of mice infected with YopP-expressing bacteria was markedly greater than that of mice infected with bacteria expressing YopJ (Figure 6C). This indicated that excessive cytotoxicity was detrimental to Y. pseudotuberculosis replication and virulence in vivo. We obtained similar results in infection of mice with bacteria containing the pYopPJn plasmid (Figure S3). Although this strain hyper-secretes YopJ and is more cytotoxic in vitro than wild-type Y. pseudotuberculosis (Figure 3), it too is attenuated in vivo as measured by survival of infected mice (Figure S3). These data indicate that limiting cytototoxicity during infection through control of YopJ secretion is critical for optimal virulence of Y. pseudotuberculosis.
Successful infection of mammalian organisms by microbial pathogens is often associated with disruption of cell death homeostasis within infected tissues. Triggering of host-cell death is thought to be an important virulence characteristic of many facultative pathogenic bacteria, since deletion of individual bacterial genes or secretion systems associated with causing cell death leads, in many cases, to attenuation of virulence in experimental infection models . However, it is likely that evolution of any given microbial pathogen has led to an optimized set of virulence traits in which any particular characteristic, such as the ability to cause cell death, is tightly regulated in relation to the other traits. We examined this hypothesis by using a system in which the degree of cytotoxicity could be modulated. We chose Yersinia as a model system, because, despite the close evolutionary relatedness of the pathogenic Yersiniae, they are heterogeneous in the extent of cell death and pathology that they cause during infection ,. This provides optimal conditions for testing whether the degree of cell death caused by a particular member of a related group of organisms might be an evolutionarily selected trait.
Recent studies have shown that two of the pathogenic Yersinia species, Y. enterocolitica and Y. pestis, possess varying degrees of cytotoxicity, and that Y. enterocolitica YopP is translocated more efficiently into cells than the homologous protein YopJ of Y. pestis . These studies also demonstrated that expressing YopP from a strong promoter on a high copy plasmid in Y. pestis enhanced the ability of Y. pestis to cause macrophage cell death in vitro. Variation also exists among different serotypes of Y. enterocolitica with respect to both YopP activity  and degree of secretion . However, nothing is currently known about the contribution of differential YopJ/YopP secretion to cytotoxicity or virulence of Yersinia during in vivo infection. Furthermore, the underlying basis for the differential secretion of YopP and YopJ, as well as differential secretion of YopP among individual Y. enterocolitica isolates, remains unclear.
The work presented here demonstrates that YopP and YopJ are differentially secreted and translocated due to a polymorphism in amino acids 10 and 11 between Y. pseudotuberculosis YopJ and Y. enterocolitica YopP. Polymorphisms at amino acid 11 are also likely to account for differences in secretion of YopP among different Y. enterocolitica serotypes. However, these amino acids are identical among YopJ proteins from sequenced strains of Y. pseudotuberculosis and Y. pestis. This suggests that selection pressures driving this difference in secretion between the Y. enterocolitica and Y. pseudotuberculosis proteins were maintained in the recent evolution of Y. pestis from Y. pseudotuberculosis. It is interesting to note that while Y. pestis YopJ contributes to host cell death and blocks cytokine secretion in vitro, as it does for enteric Yersiniae, it appears to be nonessential for virulence in a rat model of bubonic plague . Our study suggests that expression of YopP or a hypersecreted form of YopJ in Y. pestis may also attenuate virulence during in vivo infection. Our data also indicate that despite inducing higher levels of cell death in infected tissues (Figure 5), Y. pseudotuberculosis expressing YopP were attenuated for colonizing and possibly replicating within the spleen and mesenteric lymph nodes (Figure 6). An intermediate level of YopJ protein delivery therefore appears necessary for maximal virulence, as bacteria completely lacking YopJ are also deficient in colonization of the spleen following oral infection, consistent with earlier studies . Recent work indicates that YopJ is not required for replication of Y. pseudotuberculosis in the spleen if the bacteria are delivered intraperitoneally, bypassing the intestinal route . Our results therefore indicate a requirement for intermediate levels of YopJ delivery in mediating spread of bacteria to the spleen from initial sites of colonization within the intestine.
The underlying basis for why increasing cytotoxicity of Y. pseudotuberculosis infection leads to attenuation are not clear at this time, but could involve an intracellular stage during in vivo infection ,. Excessive cytotoxicity may lead to death of cells that provide an important intracellular niche for Y. pseudotuberculosis, potentially for purposes of spreading from the initial site of colonization to other tissues. Recent evidence indicates that spread of Y. pseudotuberculosis to the spleen following oral infection occurs directly from a replicating pool within the intestinal lumen, through a pathway that bypasses the mesenteric lymph nodes . Interestingly, despite the differential susceptibility of bone-marrow derived macrophages and dendritic cells to YopJ-mediated killing (Figures 1 and 3), it appears that at least within mesenteric lymph nodes, both CD11b+ (primarily macrophage) and CD11c+ (primarily dendritic) cell populations showed either high or intermediate levels of cell death when infected by YopP- or YopJ- expressing Y. pseudotuberculosis (Figure 5). A particular phagocytic cell subset within the Peyer's patches or intestinal lamina propria may be responsible for transporting Yersinia from the intestine to systemic sites, and these cells may be differentially susceptible to YopJ-mediated cell death. Recent work has highlighted the role of a particular subset of dendritic cells within the lamina propria, designated CX3CR1+ cells, in uptake of Salmonella typhimurium ,. Investigation of the particular cell types that interact with Yersinia during intestinal colonization and the utilization of mouse models enabling dendritic cell depletion are likely to provide further insight into the mechanism of Yersinia spread to internal tissues.
That higher in vitro cytotoxicity of Y. pseudotuberculosis can lead to markedly reduced virulence is somewhat surprising, particularly since we observed reduced cytokine production as well as increased cell death in mice infected with the more cytotoxic, YopP-expressing bacteria. An alternative hypothesis for the requirement for intermediate levels of cytotoxicity during Y. pseudotuberculosis infection is that proinflammatory cytokines produced during wild-type Y. pseudotuberculosis infection could contribute to bacterial spread by promoting tissue destruction. This could be blocked during infection with YopP-expressing Y. pseudotuberculosis due to death of cytokine-producing cells. In support of this model, recent work has shown that mice infected with the attenuated Δpla strain of Y. pestis control the infection without producing high levels of cytokines in contrast to wild-type infected mice, which fail to control the infection despite high levels of cytokine production . These observations may reflect the possibility that appropriate control of bacterial replication must occur very early during the infection process. The outcome of a bacterial infection depends on the interplay between host clearance mechanisms and bacterial virulence factors; misregulation of bacterial virulence factors as we observed with expression of YopP in place of YopJ therefore appears to shift the balance strongly in favor of the host.
In addition to implications for the evolution of bacterial virulence, this work sheds further light on mechanisms of Type III secretion in Yersinia. It has been suggested that mRNA sequence determines the secretion of TTSS effectors . An alternative proposal is that the amphipathic character of the N-terminal amino acids controls the extent of secretion of TTSS effectors ; this latter study further demonstrated that seemingly minor changes in the amino acid sequence of a synthetic secretion signal could result in dramatically different levels of secretion of a reporter fusion construct. In agreement with this study, we demonstrate that in the case of YopJ/P, the amino acid sequence plays a key role in controlling secretion. It may be that alteration of IS to SP at positions 10 and 11 generates a more optimal amphipathic sequence leading to enhanced secretion and translocation of YopP relative to YopJ. There may nonetheless be a contribution from the mRNA sequence that is not revealed directly by these studies. Indeed, the replacement of yopJ noncoding sequences with those of yopP to generate YopPJn from YopJn led to markedly higher translocation of the corresponding GSK fusion protein and secretion of the full length protein (Figure 3B and Figure S1). We further observed that YopE was also secreted at higher levels by Y. enterocolitica than Y. pseudotuberculosis (Figure 4A). However, the yopE coding sequences are identical between the two bacterial species. This suggests that the rules governing the secretion of proteins that possess dedicated chaperones (such as YopE) may differ from those that do not (such as YopJ/P). Individual type III effector proteins may therefore differ in the degree to which their secretion is governed by mRNA or primary amino acid sequences.
It is notable that while bacteria secreting either YopJ or YopP show cytotoxicity toward macrophages, as previously described ,, only bacteria secreting YopP or hypersecreted mutants of YopJ were cytotoxic toward DCs (Figures 1 and 3). This potent cytotoxicity exhibited by Y. enterocolitica toward DCs may be a confounding factor in the interpretation of some of the data describing the inhibition of particular aspects of DC biology such as maturation and phagocytosis ,. We did not observe reduced maturation of, or inhibition of cytokine secretion by DCs infected by Y. pseudotuberculosis, in contrast to Y. enterocolitica infected DCs (Figure S4). A recent study indicates, however, that YopJ of Y. pestis can inhibit differentiation of monocytes into DCs and also interferes with the ability of DCs to stimulate T cell proliferation . Many of these studies were performed with a monocytic cell line which can be differentiated in vitro into DC-like cells or with human monocytes isolated from peripheral blood samples. Dendritic cells in vivo are not a uniform cell population, but rather comprise a diverse array of closely related cells that differ in their activation and antigen-presentation properties ,. Furthermore, murine and human DC populations also differ with respect to their activation properties and expression of TLR molecules . Experimental differences observed with different systems may reflect potential differences between DC subsets in vivo. Different subsets of DCs may therefore exhibit different maturation or survival properties when targeted by Yersinia during in vivo infection.
Macrophage resistance to cell death in response to inflammatory stimuli such as LPS or bacterial infection is mediated by both NF-κB and p38 MAPK-dependent transcription of a variety of anti-apoptotic proteins ,. Inhibition of both NF-κB and MAPK signaling in the context of Yersinia infection is required for the full extent of Yersinia-induced macrophage cell death . Interestingly, pretreatment of DCs with the p38 MAPK inhibitor SB202190 was sufficient to raise the level of DC death following Y. pseudotuberculosis infection to that of Y. enterocolitica infected cells (Figure 2D). We did not observe differences in the ability of Y. pseudotuberculosis and Y. enterocolitica to inhibit IκB-α degradation in either macrophages or DCs (data not shown). These findings indicate that DCs and macrophages are differentially susceptible to host cell death induced by Yersinia infection, and this may depend on differential inhibition of MAPK pathways or differential regulation of MAPK-dependent genes in macrophages and dendritic cells during Yersinia infection. Data corroborating these observations have also recently been reported by Adkins et al. .
Our work uncovers a previously unappreciated feature of YopJ-dependent cell death in the context of Yersinia infection. Specifically, we have shown that this virulence property must be carefully balanced during infection by Y. pseudotuberculosis, and that shifting this balance in a way that leads to increased cell death attenuates bacterial virulence. Similar findings have recently been described in the organism Francisella novicida: bacterial genes were identified that are necessary to tightly regulate the induction of macrophage death in vitro, and mutants lacking these genes were dramatically attenuated following mouse infection . While this is reasonable in light of the Francisella intracellular lifestyle, it is surprising given the traditional viewpoint that the primary site of Yersinia replication is extracellular. Our work therefore highlights the importance of regulating host cell death during Yersinia infection, and indicates that the appropriate regulation of bacterially-induced host cell death may be a universal theme in the pathogenesis of bacterial infection.
Materials and Methods
Bone marrow was isolated from 6–8 week old C57Bl/6 mice and cultured in 12-well plates in DMEM containing 5% FCS in the presence of GM-CSF for dendritic cells (DCs)  or 10% FCS and 30% L929 cell supernatant for bone marrow macrophages (BMMs) . Cells were maintained at 37°C in a 5% CO2 humidified incubater. DCs were fed on days 2 and 4 post-isolation and infected on day 5 post-isolation. BMMs were harvested and replated into 12 or 24-well plates on days 6–7 post-isolation and infected the next day.
Bacterial strains and infection conditions
Strains used in this study are indicated in Table S1. Y. pseudotuberculosis strain IP2666 and isogenic mutants were a kind gift of Dr. James Bliska, SUNY Stonybrook. Y. enterocolitica strain 8081 was the gift of Dr. Denise Monack, Stanford University. Bacteria were routinely grown at 26°C. For infection of cultured cells, bacteria were grown shaking overnight at 26°C in 2×YT medium. Bacteria were diluted in 2×YT containing 20 mM MgCl2 and 20 mM sodium oxalate. Bacteria were grown shaking for 1 hour at 26°C followed by 37°C for 2 hours to induce Yop secretion . Bacteria were harvested, washed three times with DMEM and resuspended at the appropriate density in DMEM before being added to cells. Bacteria were spun onto the cells at 1000 RPM for 5 minutes, and the infected cells placed in a humidified tissue culture incubator at 37°C for 1 hour. Gentamicin was added to the cells 1 hour post-infection to a final concentration of 100 µg/mL, and the cells placed in the incubator until harvesting. LPS used in indicated experiments was O55∶B5 obtained from Sigma (L2880).
Primers used to amplify YopJ were identical to those previously described . A similar sized fragment containing both the ORF and flanking regions of YopP was amplified from Y. enterocolitica 8081 DNA using the following primers: Forward 5′-GAGAGAAAAGTTGCGAGAGCTG-3′. Reverse 5′-ACGTCGATATGTCATGTATAT-3′. Both YopJ and YopP amplified fragments were cloned into the SphI/EagI sites of pACYC184. pYopJP and pYopPJ were constructed by exchanging EcoNI/BstEII fragments that contained the YopJ and YopP ORFs with minimal flanking sequence from each of the parent plasmids. Site directed mutant constructs were generated by PCR-based mutagenesis using standard PCR conditions and primers containing altered base mutations. Multiple independently cloned constructs were sequenced prior to further use. GSK-tag fusion constructs were generated as follows: complimentary oligos (Invitrogen) containing the first 39 nucleotides of the GSK-3β coding sequence  flanked by XcmI and BstEII restriction sites were annealed and ligated into the XcmI/BstEII sites of pYopJ, pYopP, pYopJn, and pYopPJn plasmids.
Cell Death Assay
Cells were harvested 6 hours post-infection or 18–20 hours post-infection as indicated, and washed twice with Annexin V staining buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2) before being stained with Annexin V (Molecular Probes) and propidium iodide (Sigma) (1 µg/mL final concentration) as described in the Vybrant apoptosis assay kit (Molecular Probes). Detection of caspase-3 activation was done with the NucView™ 488 Caspase-3 fluorescent substrate (Biotium, Inc.). Flow cytometry was performed on a FACSCalibur (Becton Dickinson) followed by analysis with FlowJo software (Treestar, Inc.).
Western Blotting and Antibodies
Antibodies used were against cleaved PARP (R&D Systems) and phospho- and total-MAPKs (Cell Signaling Technologies). Antibodies against phospho-GSK-3β (Ser9) (#9336) and against GSK-3β tag (#9325) were from Cell Signaling Technologies. Secondary antibodies were horseradish peroxidase conjugated anti-rabbit or anti-mouse (Jackson Immunoresearch). BMMs and DCs were harvested 2 hrs post-infection for PARP cleavage and at indicated times for phospho-MAPK detection. Cells were lysed in buffer containing 50 mM Tris-HCl pH 8.0, 5 mM EDTA, 2% Triton X-100, 0.02% sodium azide with protease inhibitors. 1/8 of each cell lysate was run on 12.5% SDS-PAGE and transferred to PVDF membrane (Millipore Corporation) prior to Western blotting. Detection was with ECL reagent (Amersham/GE Healthcare).
Secreted Yop Analysis
Bacteria were grown overnight and diluted into 2xYT containing 20 mM MgCl2 and 20 mM sodium oxalate as described above. Bacteria were grown for 1 hr. at 25°C and 6 hr. at 37°C. The OD600 of the cultures were assayed and bacteria were spun at 4000 RPM in a clinical centrifuge. Supernatants were collected and precipitated with 10% TCA, washed with acetone, air-dried and resuspended in SDS-PAGE loading buffer. The protein samples were normalized for the OD600, run on 10% SDS-PAGE gel and analyzed by staining with Coomassie blue.
Analysis of YopJ/P translocation
The detection of translocated proteins was performed essentially as described . Briefly, HeLa cells were seeded into 24 well dishes at a density of 3×105 cells per well. Cells were infected the following day with a yopJ mutant of Y. pseudotuberculosis expressing YopJGSK, YopPGSK, YopJnGSK, or YopPJnGSK after first growing the bacteria in inducing conditions described above. 2 hours prior to infection, cells were washed once with DMEM without serum, and incubated in the same medium for the rest of the experiment. Bacteria were harvested, washed 3 times in DMEM without serum, and added to the cells at an MOI of 25. Bacteria were allowed to infect cells for three hours, after which the cells were washed once with PBS, and lysed in cell lysis buffer as described above. Cell lysates were run on 10% SDS-PAGE gels, transferred to PVDF membrane, and probed with polyclonal antibodies to phospho-GSK (Ser9). The blots were then stripped and reprobed with polyclonal antibodies to GSK tag (amino acids 1–13).
8–10 week old female C57Bl/6J mice were infected with 5×108 to 1×109 bacteria in 0.1 mL PBS by intragastric inoculation using a feeding needle in accordance with Yale University approved animal protocols. Mice were fasted for 14–16 hours prior to infection. At indicated times post-infection, mice were sacrificed by CO2 asphyxiation and the indicated organs harvested, homogenized in PBS, and dilutions plated onto LB containing 2 µg/mL irgasan. Blood was collected from infected mice just prior to sacrificing by retro-orbital bleeding and centrifuged to collect serum. Serum cytokines were assayed using the Luminex 200 instrument (Luminex Corp.) in combination with the Beadlyte® Multicytokine Detection System 2 (Millipore).
Tissues from infected mice were isolated and cryopreserved in OCT compound for sectioning or strained through nylon mesh to generate single-cell suspensions for staining and flow-cytometry analysis. For analysis of whole tissues, 10–12 µM thick sections were cut, air-dried, and fixed in 4% paraformaldehyde, followed by permeabilization in 0.1% citrate/0.1% Triton X-100. For FACS analysis, tissues were stained with appropriate antibodies (BD-Pharmingen) and fixed in 2% paraformaldehyde followed by permeabilization as above. Following fixation and permeabilization, tissues were stained with TUNEL reagent (Roche Applied Science) according to manufacturer's instructions and either visualized by microscopy using a AxioPhot 2 Micropscope with AxioVision software (Zeiss) or analyzed by flow cytometry as described above. Single-stained and unstained samples were used for compensation controls in accordance with standard FACS procedures. TUNEL+ populations were determined by gating on cells present in TUNEL-stained samples that were absent in non-TUNEL samples.
N-terminal amino acid polymorphisms modulate secretion levels of YopJ and YopP. (A) Schematic diagram of YopJ and YopP constructs described in this work. YopJ and YopP open reading frames were exchanged by digestion of pYopJ and pYopP with EcoNI and BstEII and replacing the coding sequences of YopJ/P from one vector with that of the other. (B) Alignment of N-terminal region of yopJ and yopP genes with encoded amino acid sequence. The non-coding sequences between the EcoNI site and the translation start site are indicated in lower case. The EcoNI site is underlined. (C) Sequence of YopJn, YopJ2nt and YopJ2aa mutant constructs. (D) TCA precipitated supernatants from indicated bacterial cultures grown in low calcium medium and analyzed by SDS-PAGE.
(15.17 MB PNG)
Low MOI infection of bone marrow derived macrophages reveals difference in extent of cell death caused by Y. enterocolitica and Y. pseudotuberculosis. Bone marrow derived macrophages were infected with MOI of 5 with indicated bacterial strains and assayed for annexin V and propidium iodide staining 18–20 hours post-infection.
(1.60 MB TIF)
Hypersescretion of YopJ attenuates Y. pseudotuberculosis virulence. Mice were infected orally with 5×108 cfu of indicated bacterial strains and percent survival over time post-infection was analyzed.
(1.32 MB TIF)
Maturation of dendritic cells infected by wild-type Y. pseudotuberculosis but not Y. enterocolitica or Y. pseudotuberculosis expressing YopP. (A) CD40 and CD86 surface staining on DCs 18–20 hours post-infection with indicated bacterial strains. CD40 and CD86 are upregulated on DCs treated with LPS or wild-type and plasmid-cured Y. pseudotuberculosis as well as plasmid-cured Y. enterocolitica. No upregulation is observed on DCs infected with wild-type Y. enterocolitica or Y. pseudotuberculosis expressing YopP. (B) Secretion of IL-6 and IL-12 into DC culture supernatant was assayed 18 hours post-infection. No cytokines are detectable in culture supernatants from cells infected with Y. enterocolitica. The presence of the Yersinia virulence plasmid does not appear to inhibit cytokine production in DCs infected with wild-type Y. pseudotuberculosis.
(1.87 MB TIF)
Strains and plasmids used in this study.
(0.06 MB DOC)
Percent of cells containing β-lactamase activity after infection with Y. pseudotuberculosis expressing YopE-BlaM fusion protein.
(0.03 MB DOC)
We are grateful to Jim Bliska (SUNY Stony Brook) for Y. pseudotuberculosis strains IP2666 (Yp), IP2666c, (YpP-) and IP2666 ΔyopJ, and to Denise Monack (Stanford University) for Y. enterocolitica strain 8081 (Ye). We thank Maya Kotas for assistance in generating YopJn mutant constructs. We thank Amanda Jamieson for assistance with mouse experiments. We thank Sunny Shin, Noah Palm, and Jonathan Kagan for critical reading of the manuscript and members of the Medzhitov Lab for scientific discussion.
Conceived and designed the experiments: IB RM. Performed the experiments: IB. Analyzed the data: IB. Wrote the paper: IB RM.
- 1. Monack D, Falkow S (2000) Apoptosis as a common bacterial virulence strategy. Int J Med Microbiol 290: 7–13.
- 2. Fu Y, Galan JE (1999) A Salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401: 293–297.
- 3. Lin SL, Le TX, Cowen DS (2003) SptP, a Salmonella typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation. Cell Microbiol 5: 267–275.
- 4. Glomski IJ, Decatur AL, Portnoy DA (2003) Listeria monocytogenes mutants that fail to compartmentalize listerolysin O activity are cytotoxic, avirulent, and unable to evade host extracellular defenses. Infect Immun 71: 6754–6765.
- 5. Wren BW (2003) The yersiniae–a model genus to study the rapid evolution of bacterial pathogens. Nat Rev Microbiol 1: 55–64.
- 6. Carniel E, Autenrieth I, Cornelis GR, Fukushima H, Guinet F, et al. (2006) Y. enterocolitica and Y. pseudotuberculosis. In: Dworkin M, Falkow S, Rosenberg E, Schleifer K, Stackebrandt E, editors. The Prokaryotes. New York: Springer. pp. 270–398.
- 7. Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB (2004) The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infect Immun 72: 4973–4984.
- 8. Handley SA, Dube PH, Revell PA, Miller VL (2004) Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Infect Immun 72: 1645–1656.
- 9. Portnoy DA, Wolf-Watz H, Bolin I, Beeder AB, Falkow S (1984) Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun 43: 108–114.
- 10. Bolin I, Portnoy DA, Wolf-Watz H (1985) Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect Immun 48: 234–240.
- 11. Rosqvist R, Forsberg A, Wolf-Watz H (1991) Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun 59: 4562–4569.
- 12. Ruckdeschel K, Roggenkamp A, Schubert S, Heesemann J (1996) Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils. Infect Immun 64: 724–733.
- 13. Palmer LE, Hobbie S, Galan JE, Bliska JB (1998) YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 27: 953–965.
- 14. Yao T, Mecsas J, Healy JI, Falkow S, Chien Y (1999) Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med 190: 1343–1350.
- 15. Balada-Llasat JM, Mecsas J (2006) Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system. PLoS Pathog 2: e86. doi:10.1371/journal.ppat.0020086.
- 16. Monack DM, Mecsas J, Ghori N, Falkow S (1997) Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci USA 94: 10385–10390.
- 17. Mills SD, Boland A, Sory MP, van der Smissen P, Kerbourch C, et al. (1997) Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc Natl Acad Sci USA 94: 12638–12643.
- 18. Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MF, Pettersson S, et al. (1998) The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 28: 1067–1079.
- 19. Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, et al. (2005) Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med 202: 1327–1332.
- 20. Thiefes A, Wolf A, Doerrie A, Grassl GA, Matsumoto K, et al. (2006) The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep 7: 838–844.
- 21. Mittal R, Peak-Chew SY, McMahon HT (2006) Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci USA 103: 18574–18579.
- 22. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, et al. (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211–1214.
- 23. Monack DM, Mecsas J, Bouley D, Falkow S (1998) Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 188: 2127–2137.
- 24. Bach S, Buchrieser C, Prentice M, Guiyoule A, Msadek T, et al. (1999) The high-pathogenicity island of Yersinia enterocolitica Ye8081 undergoes low-frequency deletion but not precise excision, suggesting recent stabilization in the genome. Infect Immun 67: 5091–5099.
- 25. Rakin A, Noelting C, Schubert S, Heesemann J (1999) Common and specific characteristics of the high-pathogenicity island of Yersinia enterocolitica. Infect Immun 67: 5265–5274.
- 26. Viboud GI, Bliska JB (2001) A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. Embo J 20: 5373–5382.
- 27. Ruckdeschel K, Richter K, Mannel O, Heesemann J (2001) Arginine-143 of Yersinia enterocolitica YopP crucially determines isotype-related NF-kappaB suppression and apoptosis induction in macrophages. Infect Immun 69: 7652–7662.
- 28. Denecker G, Totemeyer S, Mota LJ, Troisfontaines P, Lambermont I, et al. (2002) Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells. Infect Immun 70: 3510–3520.
- 29. Zauberman A, Cohen S, Mamroud E, Flashner Y, Tidhar A, et al. (2006) Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun 74: 3239–3250.
- 30. Erfurth SE, Grobner S, Kramer U, Gunst DS, Soldanova I, et al. (2004) Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells. Infect Immun 72: 7045–7054.
- 31. Trulzsch K, Geginat G, Sporleder T, Ruckdeschel K, Hoffmann R, et al. (2005) Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model. J Immunol 174: 4244–4251.
- 32. Autenrieth SE, Soldanova I, Rosemann R, Gunst D, Zahir N, et al. (2007) Yersinia enterocolitica YopP inhibits MAP kinase-mediated antigen uptake in dendritic cells. Cell Microbiol 9: 425–437.
- 33. Velan B, Bar-Haim E, Zauberman A, Mamroud E, Shafferman A, et al. (2006) Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration. Infect Immun 74: 6365–6376.
- 34. Denecker G, Declercq W, Geuijen CA, Boland A, Benabdillah R, et al. (2001) Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid. J Biol Chem 276: 19706–19714.
- 35. Zhang Y, Bliska JB (2003) Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect Immun 71: 1513–1519.
- 36. Zhang Y, Ting AT, Marcu KB, Bliska JB (2005) Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J Immunol 174: 7939–7949.
- 37. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221–227.
- 38. Pettersson J, Holmstrom A, Hill J, Leary S, Frithz-Lindsten E, et al. (1999) The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32: 961–976.
- 39. Edqvist PJ, Olsson J, Lavander M, Sundberg L, Forsberg A, et al. (2003) YscP and YscU regulate substrate specificity of the Yersinia type III secretion system. J Bacteriol 185: 2259–2266.
- 40. Anderson DM, Schneewind O (1997) A mRNA signal for the type III secretion of Yop proteins by Yersinia enterocolitica. Science 278: 1140–1143.
- 41. Lloyd SA, Norman M, Rosqvist R, Wolf-Watz H (2001) Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals. Mol Microbiol 39: 520–531.
- 42. Lloyd SA, Sjostrom M, Andersson S, Wolf-Watz H (2002) Molecular characterization of type III secretion signals via analysis of synthetic N-terminal amino acid sequences. Mol Microbiol 43: 51–59.
- 43. Ramamurthi KS, Schneewind O (2003) Yersinia yopQ mRNA encodes a bipartite type III secretion signal in the first 15 codons. Mol Microbiol 50: 1189–1198.
- 44. Garcia JT, Ferracci F, Jackson MW, Joseph SS, Pattis I, et al. (2006) Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag. Infect Immun 74: 5645–5657.
- 45. Lemaitre N, Sebbane F, Long D, Hinnebusch BJ (2006) Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun 74: 5126–5131.
- 46. Auerbuch V, Isberg RR (2007) Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10. Infect Immun 75: 3561–3570.
- 47. Pujol C, Bliska JB (2003) The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 71: 5892–5899.
- 48. Pujol C, Bliska JB (2005) Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin Immunol 114: 216–226.
- 49. Barnes PD, Bergman MA, Mecsas J, Isberg RR (2006) Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine. J Exp Med 203: 1591–1601.
- 50. Niess JH, Brand S, Gu X, Landsman L, Jung S, et al. (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254–258.
- 51. Hapfelmeier S, Muller AJ, Stecher B, Kaiser P, Barthel M, et al. (2008) Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. J Exp Med 205: 437–450.
- 52. Lathem WW, Price PA, Miller VL, Goldman WE (2007) A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315: 509–513.
- 53. Lindner I, Torruellas-Garcia J, Kolonias D, Carlson LM, Tolba KA, et al. (2007) Modulation of dendritic cell differentiation and function by YopJ of Yersinia pestis. Eur J Immunol 37: 2450–2462.
- 54. Niess JH, Reinecker HC (2006) Dendritic cells: the commanders-in-chief of mucosal immune defenses. Curr Opin Gastroenterol 22: 354–360.
- 55. Sato K, Fujita S (2007) Dendritic cells: nature and classification. Allergol Int 56: 183–191.
- 56. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987–995.
- 57. Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, et al. (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341–345.
- 58. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, et al. (2005) Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis–CREB and NF-kappaB as key regulators. Immunity 23: 319–329.
- 59. Adkins I, Schulz S, Borgmann S, Autenrieth IB, Grobner S (2008) Differential roles of Yersinia outer protein P-mediated inhibition of nuclear factor-kappa B in the induction of cell death in dendritic cells and macrophages. J Med Microbiol 57: 139–144.
- 60. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, et al. (2007) In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci USA 104: 6037–6042.
- 61. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693–1702.
- 62. Celada A, Gray PW, Rinderknecht E, Schreiber RD (1984) Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med 160: 55–74.